Upstart e-cigarette makers are vying to get their products prescribed on the NHS, as they target a potentially lucrative new market before Big Tobacco commits to the lengthy licensing process. [...]
Several companies are now pursuing a medicines authorisation. NJOY, which has 3.9 per cent of the $5bn US market, according to Nielsen data, is “far on in the development of its application”, a person close to the company said.
NJOY considers medical licensing an opportunity to expand into the UK, where it has a limited presence, they added.